<DOC>
	<DOCNO>NCT02477267</DOCNO>
	<brief_summary>The primary objective study compare bioavailability test formulation Buprenorphine Naloxone Sublingual ( SL ) spray single dose Suboxone® ( buprenorphine naloxone ) sublingual film , fast condition .</brief_summary>
	<brief_title>Study Buprenorphine-Naloxone Sublingual Spray Suboxone® Sublingual Film Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Meets protocolspecified criterion qualification contraception Is willing able remain confine study unit entire duration treatment period comply restriction relate food , drink medication Voluntarily consent participate provide write informed consent prior protocolspecific procedure Has history current use overthecounter medication , dietary supplement , drug ( include nicotine alcohol ) outside protocolspecified parameter Has sign , symptom history condition , per protocol opinion investigator , might compromise : 1. safety wellbeing participant study staff ; 2. safety wellbeing participant 's offspring ( pregnancy breastfeed ) ; 3. analysis result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>